NASDAQ:INBS
Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc.'s revenue grew 38.1% in fiscal 2026 to $4.2M while operating margin rose to −299.1%. Free cash flow was −$12.1M, −285.9% of revenue, and the diluted share count rose 179.3%.Summary generated from Intelligent Bio Solutions Inc.'s SEC filings. Latest annual report filed Aug 19, 2026.
Key statistics
Fiscal 2026 from SEC filings. MethodologyRevenue (FY26)$4.2M
Revenue growth+38.1%
Revenue, 5-yr CAGR+16.3%
Gross margin48.6%
Operating margin−299.1%
Net margin−294.9%
ROICn/a
Return on equity−292.3%
Debt / equityn/a
Free cash flow−$12.1M
FCF margin−285.9%
Share count change+179.3%
Financials
| Item | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Revenue | 0 | 1 | 3 | 3 | 4 |
| Operating income | −8 | −13 | −10 | −11 | −13 |
| Net income | −8 | −11 | −10 | −11 | −12 |
| Free cash flow | n/a | n/a | −10 | −10 | −12 |
Recent filings
- 8-KOther events
Sep 11, 2026 - 8-KRegulation FD disclosure
Sep 9, 2026 - 8-KEntry into a material agreement
Sep 2, 2026 - 8-KRegulation FD disclosure
Sep 1, 2026 - 8-KRegulation FD disclosure
Aug 28, 2026 - 8-KResults of operations and financial condition
Aug 19, 2026 - 10-KAnnual report for the fiscal year ended Jun 30, 2026
Aug 19, 2026 - 8-KRegulation FD disclosure
Aug 11, 2026